Your browser doesn't support javascript.
loading
Clinical analysis of pathologic complete responders in advanced-stage ovarian cancer.
LaFargue, Christopher J; Handley, Katelyn F; Fleming, Nicole D; Nick, Alpa M; Chelariu-Raicu, Anca; Fellman, Bryan; Castellano, Tara; Ogasawara, Aiko; Hom-Tedla, Marianne; Blake, Erin A; da Costa, Alexandre A B A; Crim, Aleia K; Rauh-Hain, Alejandro; Westin, Shannon N; Coleman, Robert L; Matsuo, Koji; Baiocchi, Glauco; Hasegawa, Kosei; Moore, Kathleen; Sood, Anil K.
Afiliação
  • LaFargue CJ; Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, United States of America.
  • Handley KF; Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, United States of America.
  • Fleming ND; Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, United States of America.
  • Nick AM; Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, United States of America.
  • Chelariu-Raicu A; Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, United States of America.
  • Fellman B; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX, United States of America.
  • Castellano T; Department of Gynecologic Oncology, Stephenson Cancer Center, University of Oklahoma Health Sciences Center, Oklahoma City, OK, United States of America.
  • Ogasawara A; Department of Gynecologic Oncology, Saitama Medical University International Medical Center, Saitama, Japan.
  • Hom-Tedla M; Department of Gynecologic Oncology, University of Southern California, Los Angeles, CA, United States of America.
  • Blake EA; Department of Gynecologic Oncology, University of Southern California, Los Angeles, CA, United States of America.
  • da Costa AABA; Department of Medical Oncology, A.C. Camargo Cancer Center, Sao Paulo, Brazil.
  • Crim AK; Department of Gynecologic Oncology, Stephenson Cancer Center, University of Oklahoma Health Sciences Center, Oklahoma City, OK, United States of America.
  • Rauh-Hain A; Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, United States of America.
  • Westin SN; Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, United States of America.
  • Coleman RL; Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, United States of America.
  • Matsuo K; Department of Gynecologic Oncology, University of Southern California, Los Angeles, CA, United States of America.
  • Baiocchi G; Department of Gynecologic Oncology, A.C. Camargo Cancer Center, Sao Paulo, Brazil.
  • Hasegawa K; Department of Gynecologic Oncology, Saitama Medical University International Medical Center, Saitama, Japan.
  • Moore K; Department of Gynecologic Oncology, Stephenson Cancer Center, University of Oklahoma Health Sciences Center, Oklahoma City, OK, United States of America.
  • Sood AK; Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, United States of America. Electronic address: asood@mdanderson.org.
Gynecol Oncol ; 165(1): 82-89, 2022 04.
Article em En | MEDLINE | ID: mdl-35216808
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas / Terapia Neoadjuvante Tipo de estudo: Observational_studies / Prognostic_studies Limite: Female / Humans Idioma: En Revista: Gynecol Oncol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas / Terapia Neoadjuvante Tipo de estudo: Observational_studies / Prognostic_studies Limite: Female / Humans Idioma: En Revista: Gynecol Oncol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos